Skip to main content
Clinical Trials/NCT01007305
NCT01007305
Completed
Not Applicable

Elective Bilateral Salpingo-oophorectomy Versus Ovarian Conservation: A Pilot Randomized, Controlled Trial

University of California, San Francisco2 sites in 1 country20 target enrollmentMay 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oophorectomy
Sponsor
University of California, San Francisco
Enrollment
20
Locations
2
Primary Endpoint
Recruitment rate
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

This is a pilot study to assess the feasibility of conducting a randomized, blinded, controlled trial of bilateral salpingo-oophorectomy (BSO, removal of the ovaries and fallopian tubes) versus ovarian conservation among premenopausal women age 40 years and greater who plan to undergo hysterectomy for a benign gynecologic condition. Subjects will be randomized to BSO or ovarian conservation concomitant with hysterectomy and remain blinded to group assignment. The primary goal of this pilot is to determine the feasibility of recruiting and retaining study participants in anticipation of conducting a larger, multi-centered trial. However, the investigators will also obtain baseline data and follow-up measures at 6 weeks and 6 months after surgery. Outcomes will be assessed in several domains that the investigators hypothesize may be effected by oophorectomy: cardiovascular health, skeletal health, sexual functioning, and health-related quality-of-life.

Registry
clinicaltrials.gov
Start Date
May 2009
End Date
April 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Plans to undergo hysterectomy for any non-cancerous gynecologic condition, including symptomatic fibroids, abnormal bleeding, pelvic pain, or pelvic organ prolapse. Hysterectomy may be done abdominally, vaginally or laparoscopically
  • Premenopausal defined as having at least one menses in the 3 months prior to surgery
  • Age \> or = 40 years
  • Speaks English or Spanish

Exclusion Criteria

  • Personal or family history of breast and/or ovarian cancer (at least one first degree relative with a diagnosis of breast or ovarian cancer) or a known BRCA mutation
  • Known or suspected adnexal mass by physical exam or radiologic imaging study
  • Gynecologist recommends BSO for treatment of pelvic pain and/or endometriosis
  • Known history of coronary heart disease defined as any of the following: prior myocardial infarction, history of angioplasty, history of angina, admission to the hospital for evaluation of chest pain, or use of nitroglycerin to treat angina
  • History of stroke
  • History of osteoporosis

Outcomes

Primary Outcomes

Recruitment rate

Time Frame: start of study

Flow-mediated diameter of the brachial artery

Time Frame: Baseline and 6 months follow-up

Serum bone turnover markers

Time Frame: Baseline and 6 months follow-up

Sexual functioning and quality-of-life questionnaires

Time Frame: Baseline and 6 month follow-up

Study Sites (2)

Loading locations...

Similar Trials